CXCL14 and urinary bladder carcinoma: In combination with previous findings that CXCL14 overexpression is consistent with chemoresistance in bladder cancer patients, we classified abnormal CXCL14 expressing CAFs as differentiated iCAFs or undifferentiated naïve CAFs.